Abstract ESC Pisa

Similar documents
Patterns of Left Ventricular Remodeling in Chronic Heart Failure: The Role of Inadequate Ventricular Hypertrophy

Ivana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic, A Djordjevic Dikic, B Beleslin, M Nikolic, M Petrovic, D Popovic

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome

Exercise Testing/Echocardiography in Asymptomatic AS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

Mechanisms of False Positive Exercise Electrocardiography: Is False Positive Test Truly False?

QUIZ 1. Tuesday, March 2, 2004

Online Appendix (JACC )

LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Coronary artery disease (CAD) risk factors

Abstract nr AHA, Chicago November European Heart Journal Cardiovascular Imaging, in press. Nr Peter Blomstrand

Prognostic Value of Cardiopulmonary Exercise Testing in Patients with Atrial Fibrillation

Echocardiographic Correlates of Pulmonary Artery Systolic Pressure

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Dr. Dermot Phelan MB BCh BAO PhD European Society of Cardiology 2012

Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Plasma MR-proADM is superior to NTproBNP for all-cause short term mortality prediction in acute pulmonary embolism.

Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema

The Role of Ventricular Electrical Delay to Predict Left Ventricular Remodeling With Cardiac Resynchronization Therapy

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

The Ross Procedure: Outcomes at 20 Years

Natural History and Echo Evaluation of Aortic Stenosis

Quantitation of right ventricular dimensions and function

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;

Mechanisms of heart failure with normal EF Arterial stiffness and ventricular-arterial coupling. What is the pathophysiology at presentation?

Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Conflict of interest: none declared

The REDUCE LAP Heart Failure Trial. David M Kaye MD, PhD on behalf of the REDUCE LAP HF Investigators

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies

Cardiovascular hemodynamics in the stress echo lab with open-source software

Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy

좌심실수축기능평가 Cardiac Function

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Michigan Society of Echocardiography 30 th Year Jubilee

Assessing the Impact on the Right Ventricle

Management of Tricuspid Regurgitation

To Correlate Ejection Fraction with 6 Minute Walked Distance and Quality of Life in Patients with Left Ventricular Heart Failure

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Association of Common Carotid Artery Doppler-Determined Dicrotic Notch Velocity With the Left Ventricular Ejection Fraction

E/Ea is NOT an essential estimator of LV filling pressures

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

HEMODYNAMIC ASSESSMENT

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?

Stress echo workshop STRESSORS

Prognostic Value of Left Ventricular Dyssynchrony by Phase Analysis of Gated SPECT in Patients Undergoing Myocardial Perfusion Imaging

ORIGINAL. Keywords : multidetector-row computed tomography, myocardial infarction, cardiac function

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

MASSACHUSETTS INSTITUTE OF TECHNOLOGY

Cronicon CARDIOLOGY. N Laredj*, HM Ali Lahmar and L Hammou. Abstract

Citation for published version (APA): Lok, D. J. A. (2013). Novel markers in chronic heart failure. Groningen: s.n.

Effects of heart rate reduction with ivabradine on left ventricular remodeling and function:

Rita Calé, Miguel Mendes, António Ferreira, João Brito, Pedro Sousa, Pedro Carmo, Francisco Costa, Pedro Adragão, João Calqueiro, José Aniceto Silva.

Chronic Primary Mitral Regurgitation

Fetal gene upregulation by 1-wk TAC is significantly increased in mice lacking RGS2.

Aortic stenosis aetiology: morphology of calcific AS,

Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes

Heart Failure. Guillaume Jondeau Hôpital Bichat, Paris, France

The right heart: the Cinderella of heart failure

Left Ventricular Ejection Fraction >35%

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey

Highlights from EuroEcho 2009 Echo in cardiomyopathies

10/7/2013. Systolic Function How to Measure, How Accurate is Echo, Role of Contrast. Thanks to our Course Director: Neil J.

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Aortic valve Stenosis: Insights in the evaluation of LV function. Erwan DONAL Cardiologie CHU Rennes

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

The new Guidelines: Focus on Chronic Heart Failure

Advanced Echocardiography in the Evaluation of Chemotherapy Patients

Diagnosis is it really Heart Failure?

Aortic valve implantation using the femoral and apical access: a single center experience.

Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016

BIOAUTOMATION, 2009, 13 (4), 89-96

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Is normal ejection fraction equivalent to normal systolic function?

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

A New Method to Rapidly Evaluate LVEF from a Contractility Polar Map. Lebeau et al.

Clinical Outcome in Patients with Aortic Stenosis

Brief View of Calculation and Measurement of Cardiac Hemodynamics

ONLINE DATA SUPPLEMENT. Impact of Obstructive Sleep Apnea on Left Ventricular Mass and. Diastolic Function

How does the heart pump? From sarcomere to ejection volume

Midwall Fibrosis and 5-Year Outcome In Patients With Moderate and Severe Aortic Stenosis Brief Title: Midwall fibrosis in aortic stenosis

HFpEF: How to optimise management

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

Fetal cardiovascular parameters for the prediction of postnatal cardiovascular risk in intrauterine growth-restriction?

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Rotation: Echocardiography: Transthoracic Echocardiography (TTE)

Objectives. Diastology: What the Radiologist Needs to Know. LV Diastolic Function: Introduction. LV Diastolic Function: Introduction

Transcription:

Abstract ESC 82441 Maximal left ventricular mass-to-power output: A novel index to assess left ventricular performance and to predict outcome in patients with advanced heart failure FL. Dini 1, D. Mele 2, U. Conti 3, P. Ballo 4, MG. Delle Donne 1, P. Fontanive 3, V. Di Bello 1, M. Marzilli 1 - (1) University Hospital, Cardiac and Thoracic Department, Pisa, Italy (2) University of Ferrara, S. Anna Hospital, Cardiovascular Institute, Ferrara, Italy (3) Santa Chiara Hospital, Cardiovascular Diseases Unit 2, Pisa, Italy (4) Santa Maria Annunziata Hospital, Department of Cardiology, Florence, Italy Pisa

BACKGROUND Similarly to any mechanical engine, whose performance is proportional to the power generated with respect to weight, the left ventricle can be viewed as a power generator whose performance can be related to left ventricular muscular mass. Therefore, indices that relate maximal left ventricular power output and left ventricular mass, such as maximal power output-to-lv mass (LVPOMmax) and maximal indexed left ventricular mass-to-power output (LVMPOmax), may be proposed as novel measures for estimating left ventricular systolic function. These indices can be assessed by Doppler echocardiography and appear to be useful to risk stratify patients with left ventricular systolic dysfunction, especially those with advanced heart failure where the prognostic value of left ventricular ejection fraction has been challenged.

AIM OF THE STUDY This Doppler-echocardiographic study was designed to evaluate LVPOMmax and LVMPOmax in patients with advanced HF compared to healthy subjects and to assess their prognostic value..

METHODS Sixty-six consecutive patients with heart failure due to left ventricular systolic dysfunction (54 patients with advanced HF [LVEF <35%] and 12 controls) presenting at the Biomedical Application Laboratory of Cardiovascular Unit 2 Tito Giulio Sicca of the Santa Chiara Hospital, Pisa, were studied. All patients and healthy subjects underwent an ultrasound examination at baseline and during bicycle semi-supine exercise (Figure 1). LV power output (LVPO) was measured at rest and at peak exercise. Maximal LVPO (watt) was calculated as the maximal product of 133 10-6 x stroke volume (ml) x mean arterial pressure (mmhg) x heart rate. LV mass was assessed according to the recent recommendations. Receiver operating characteristic (ROC) curves were generated to define cut-off values for outcome predictors.

Power ouput (watt) = 0.133 Stroke Volume (l) Mean BP (mmhg) HR 60 Figure 1. All patients and healthy subjects underwent an ultrasound examination at baseline and during bicycle semi-supine exercise. Graded bicycle semi-supine exercise was performed at an initial workload of 20 watts lasting for one minute; thereafter the workload was increased stepwise by 10 watts every minute.

RESULTS LVMPOmax in controls and in patients with HF are illustrated in Figure 2. Using univariate logistic regression analysis, LVMPOmax emerged as the best predictor of outcome (OR 1.059, p=0.0006) followed by maximal LVPO and LVEF. The only predictors of outcome at multivariate logistic regression analysis were LVMPOmax (OR 1.013, p=0.0038) and LV EF at peak exercise (0.878, p=0.014). LVMPOmax >87 g/m2/watt exhibited the greatest area under the curve for HF-related events (0.94, p<0.0001). Kaplan-Maier event-free survival curves in patients categorized according to LVMPOmax are shown in Figure 3. the comparison of ROC curves between LVMPOmax and LVEF at rest is displayed in Figure 4.

Max LV mass-power Output Max LV mass-power Output A B 220 200 180 160 140 120 100 80 60 40 20 0 (g/m 2 /watt) (g/m 2 /watt) 220 200 180 160 140 120 100 80 60 P<0.0001 40 P<0.0001 20 Controls Heart Failure No Events Cardiac Events Figure 2. Indexed left ventricular mass-to-power output in patients with heart failure and in controls (A) and in patients with or without cardiac events at follow-p (B).

Peak LV mass-to-power output <87 g/m 2 /watt Peak LV mass-to-power output 87 g/m 2 /watt P<0.0001 Figure 3. Event-free survival in patients with heart failure categorized according to peak mass-to-power (that reflects the extent of indexed LV mass that is necessary to develop one watt of power).

Sensitivity 100 Peak LV Mass-to-Power LV EF 0 0 100 100-Specificity P=0.011 Figure 4. Receiver-operating characteristic curves comparing resting left ventricular ejection fraction and peak mass-to-power for the prediction of adverse events at follow-up.

CONCLUSION Estimation of indices that relate maximum left ventricular power to myocardial mass may be useful to evaluate left ventricular performance. In this study, assessment of LVMPOmax during exercise stress echocardiography appeared to effectively contribute to discriminate the outcome among patients with heart failure and severely reduced ejection fraction.